Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.
作者信息
Cleary Erin M, Byron R Kate, Hinely Katherine A, Talley Allison W, Costantine Maged M, Rood Kara M
机构信息
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.
出版信息
Obstet Gynecol. 2020 Nov;136(5):902-903. doi: 10.1097/AOG.0000000000004126.
Abstract
摘要
相似文献
1
Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.孕妇和产后妇女中皮下注射丁丙诺啡缓释剂的使用情况
Obstet Gynecol. 2020 Nov;136(5):902-903. doi: 10.1097/AOG.0000000000004126.
2
Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.延长释放制剂与口服丁丙诺啡用于妊娠期间的阿片类药物维持治疗：母婴结局。
Eur J Obstet Gynecol Reprod Biol. 2024 Jun;297:106-110. doi: 10.1016/j.ejogrb.2024.04.003. Epub 2024 Apr 7.
3
Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.用于阿片类物质使用障碍的每月一次皮下注射丁丙诺啡（Sublocade）。
Med Lett Drugs Ther. 2018 Feb 26;60(1541):35-37.
4
Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.阿片类药物耐受或丁丙诺啡/丁丙诺啡-纳洛酮复合制剂依赖患者的围产期麻醉管理
Clin Obstet Gynecol. 2017 Jun;60(2):447-458. doi: 10.1097/GRF.0000000000000288.
5
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention.丁丙诺啡药物治疗阿片类药物使用障碍：与产后治疗保留相关因素的研究。
Am J Addict. 2021 Jan;30(1):43-48. doi: 10.1111/ajad.13084. Epub 2020 Jul 16.
6
High-Dose Buprenorphine Initiation in the Management of Opioid Use Disorder in Pregnancy.高剂量丁丙诺啡在妊娠合并阿片类药物使用障碍管理中的应用。
Obstet Gynecol. 2024 Jun 1;143(6):815-818. doi: 10.1097/AOG.0000000000005572. Epub 2024 Apr 4.
7
Pharmacological Management of Opioid Use Disorder in Pregnant Women.孕妇阿片类物质使用障碍的药物治疗
CNS Drugs. 2015 Aug;29(8):625-36. doi: 10.1007/s40263-015-0273-8.
8
Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.与妊娠后相比，妊娠期间经剂量调整的舌下含服丁丙诺啡血浆浓度较低。
Am J Obstet Gynecol. 2017 Jan;216(1):64.e1-64.e7. doi: 10.1016/j.ajog.2016.09.095. Epub 2016 Sep 26.
9
Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.美沙酮与丁丙诺啡用于妊娠阿片类药物依赖妇女：一项前瞻性多中心研究。
Eur J Clin Pharmacol. 2011 Oct;67(10):1053-9. doi: 10.1007/s00228-011-1049-9. Epub 2011 May 3.
10
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain.急性疼痛情况下用于阿片类物质使用障碍的早期长效丁丙诺啡
J Addict Med. 2024;18(5):608-609. doi: 10.1097/ADM.0000000000001333. Epub 2024 May 31.
引用本文的文献
1
Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes.孕期阿片类物质使用障碍治疗的成本效益及其对分娩结局的影响。
JAMA Pediatr. 2025 Sep 8. doi: 10.1001/jamapediatrics.2025.3067.
2
COVID-19 Knowledge, Message Perceptions and Behaviors among Pregnant and Postpartum Women During the Early Months of the COVID-19 Pandemic in the United States.美国新冠疫情最初几个月期间孕妇和产后女性的新冠知识、信息认知及行为
Matern Child Health J. 2025 May 10. doi: 10.1007/s10995-025-04095-6.
3
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy.孕期使用丁丙诺啡长效注射剂（商品名：希乐凯德）治疗阿片类物质使用障碍。
Am J Addict. 2025 Sep;34(5):485-494. doi: 10.1111/ajad.70034. Epub 2025 Apr 28.
4
Patterns of Medication for Opioid Use Disorder During Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014-2021.2014 - 2021年，7个临床地点，母婴和婴儿临床网络（MAT - LINK）中孕期阿片类物质使用障碍的药物治疗模式
J Addict Med. 2025;19(2):208-215. doi: 10.1097/ADM.0000000000001426. Epub 2024 Dec 12.
5
What to Expect With Pregnant or Postpartum Prescribing of Extended-Release Buprenorphine (CAM2038).妊娠或产后使用缓释丁丙诺啡（CAM2038）的注意事项
J Clin Gynecol Obstet. 2023 Dec;12(3):110-116. doi: 10.14740/jcgo919. Epub 2023 Dec 28.
本文引用的文献
1
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.孕妇阿片类药物使用障碍的药物治疗（MOMs）：比较缓释和每日丁丙诺啡制剂的实用随机试验的设计考虑因素。
Contemp Clin Trials. 2020 Jun;93:106014. doi: 10.1016/j.cct.2020.106014. Epub 2020 Apr 27.
2
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.丁丙诺啡药理学综述：透黏膜和长效制剂的更新。
J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457.
Zotero 插件